Epithelial-mesenchymal transition: NF-κB takes center stage

Cell Cycle

Volumn 3, Issue 12, 2004, Pages 1477-1480

  Huber, Margit A ^a,b   Beug, Hartmut ^a   Wirth, Thomas ^c  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Epithelial mesenchymal transition; Metastasis; Nf B; Ras; TGF

Indexed keywords

ANTINEOPLASTIC AGENT; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR FKHRL1; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL PROLIFERATION; CELL PROTECTION; DRUG TARGETING; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; LUNG METASTASIS; MALIGNANT TRANSFORMATION; MESENCHYME; MORPHOGENESIS; NONHUMAN; PROTEIN INDUCTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION;

EID: 17144386589     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.3.12.1280     Document Type: Review

References (29)

1. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2:563-72.
2. Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer :From innocent bystander to major culprit. Nat Rev Cancer 2002; 2:301-10.
3. Grünert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 2003; 4:657-65.
4. Kang Y, Massagué J. Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 2004; 118:277-9.
5. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2:442-54.
6. Greenburg G, Hay ED. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 1982; 95:333-9.
7. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995; 154 :8-20.
8. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15:740-6.
9. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001; 98:10356-61.
10. Oft M, Heider KH, Beug H. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 1998; 8:1243-52.
11. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996; 10:2462-77.
12. Massague J, Wotton D. Transcriptlonal control by the TGF-β/Smad signaling system. EMBO J 2000; 19:1745-54.
13. Oft M, Akhurst R, Balmain A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nature Cell Biol 2002; 4:487-94.
14. Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H, Grünert S. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: Dissection of Ras signaling pathways. J Cell Biol 2002; 156:299-313.
15. Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 2004; 114:569-81.
16. Jechlinger M, Grünert S, Tamir IH, Janda E, Lüdemann S, Waerner T, Seither P, Weith A, Beug H, Kraut N. Expression profiling of epithelial plasticity in tumor progression. Oncogene 2003; 22:7155-69.
17. Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS, Sonenshein GE. Transient activation of NF-κB through a TAK1/IKK kinase pathway by TGF-β1 inhibits AP-1/SMAD signaling and apoptosis: Implications in liver tumor formation. Oncogene 2003; 22:412-25.
18. Richmond A. NF-κB, chemokine gene transcription and tumour growth. Nat Rev Immunol 2002; 2:664-74.
19. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004; 117:421-6.
20. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY, Zou Y, Bao S, Hanada N, Saso H, Kobayashi R, Hung MC. IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004; 117:225-237.
21. Lin L, Hron JD, Peng SL. Regulation of NF-κB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 2004; 21:203-13.
22. Seoane J, Le HV, Shen L, Anderson SA, Massague J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 2004; 117:211-23.
23. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ, Marinkovich MP, Tao S, Lin Q, Kubo Y, Khavari PA. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 2003; 421: 639-43.
24. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, Jacks T, Tuveson DA. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001; 15:3243-8.
25. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118:285-96.
26. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117:927-39.
27. Sosic D, Richardson JA, Yu K, Ornitz DM, Olson EN. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-κB activity. Cell 2003; 112:169-80.
28. Sosic D, Olson EN. A new twist on Twist. Modulation of the NF-κB pathway. Cell Cycle 2003; 2:76-8.
29. Karin M, Yamamoto Y, Wang QM. The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov 2004; 3:17-26.